제 품 PRODUCT

Inform your doctor immediately if you (or your child): could not be seeing as well as before starting SABRIL; begin to trip, run across points, or are much more clumsy than normal vigabatrin rems survey; are surprised by things or people can be found in front of you that seem to come out of nowhere; or if your baby is acting differently than normal.

The Vigabatrin REMS Program is required by the FDA to ensure notified risk-benefit choices prior to starting therapy, and to make sure ideal use vigabatrin while patients are dealt with. It is not feasible for your healthcare provider to know when vision loss will certainly take place.

It is suggested that your healthcare provider test your (or your youngster's) vision before or within 4 weeks after starting SABRIL and at least every 3 months during treatment till SABRIL is quit. If you or your child have any side effect that bothers you or that does not go away, tell your healthcare supplier.

If you are pregnant or plan to obtain pregnant, tell your health care provider. If vision screening can not be done, your doctor might continue prescribing SABRIL, yet will not be able to expect any kind of vision loss. If vision examinations are refrained consistently, your doctor may quit suggesting SABRIL for you (or your youngster).